The increasing prevalence of chronic kidney disease (CKD), with its associated high annual rates of mortality and cardiovascular complications ( 1 -3 ), is a major public health problem. In Japan, clinical practice guidelines established by the Japanese Society of Nephrology estimate that 18.7% of adults have CKD, which is defined as kidney damage or glomerular filtration rate (GFR) < 60 mL/min/1.73 m 2 for 3 months or more regardless of cause ( 4 ), and 4.1% have moderate or severe CKD ( 5 ). Identifying risk factors for CKD is critical in order to devise effective, population-based preventive strategies. Obesity is also a major worldwide public health problem. Obesity increases the risk of cardiovascular disease, diabetes, hypertension, and dyslipidemia (6, 7). However, few studies have examined the relationship between excess weight and CKD risk. Obese patients are at a higher risk for focal segmental glomerulosclerosis and glomerulomegaly (8) Vol. 31, No. 8 (2008) (9). In Western countries, many patients have an estimated GFR (eGFR) of less than 60 mL/min/1.73 m 2 or a body mass index (BMI) of 30 kg/m 2 or more. However, the risk of slightly elevated weight (BMI, 22.0 to 24.9 kg/m 2 ) in a Japanese population for mildly reduced renal function (eGFR, 60 to 90 mL/min/1.73 m 2 ) is not clear. We evaluated the relationship of BMI to potential risk factors such as hypertension, hyperglycemia, and lipids, as well as to renal function, using cross-sectional data from community-dwelling participants.
Introduction
The increasing prevalence of chronic kidney disease (CKD), with its associated high annual rates of mortality and cardiovascular complications ( 1 -3 ), is a major public health problem. In Japan, clinical practice guidelines established by the Japanese Society of Nephrology estimate that 18.7% of adults have CKD, which is defined as kidney damage or glomerular filtration rate (GFR) < 60 mL/min/1.73 m 2 for 3 months or more regardless of cause ( 4 ), and 4.1% have moderate or severe CKD ( 5 ) . Identifying risk factors for CKD is critical in order to devise effective, population-based preventive strategies. Obesity is also a major worldwide public health problem. Obesity increases the risk of cardiovascular disease, diabetes, hypertension, and dyslipidemia (6, 7) . However, few studies have examined the relationship between excess weight and CKD risk. Obese patients are at a higher risk for focal segmental glomerulosclerosis and glomerulomegaly (8) , and almost half of patients rapidly develop advanced renal failure (9) . In Western countries, many patients have an estimated GFR (eGFR) of less than 60 mL/min/1.73 m 2 or a body mass index (BMI) of 30 kg/m 2 or more. However, the risk of slightly elevated weight (BMI, 22.0 to 24.9 kg/m 2 ) in a Japanese population for mildly reduced renal function (eGFR, 60 to 90 mL/min/1.73 m 2 ) is not clear. We evaluated the relationship of BMI to potential risk factors such as hypertension, hyperglycemia, and lipids, as well as to renal function, using cross-sectional data from community-dwelling participants.
Methods

Subjects
Participants were recruited at the time of their annual health examination in a rural town that has a total population of 11,136 (as of April 2002) and located in Ehime Prefecture, Japan, in 2002. Among the 9,133 adults aged 19 to 90 years in this population, 3,164 (34.6%) subjects met the eligibility requirements to participate in the study. Information on medical history, present conditions, and drugs was obtained by interview. Subjects with a clinical history of stroke, transient ischemic attack, myocardial infarction, or angina were excluded. Subjects taking medications for hypertension, diabetes, or dyslipidemia were also excluded from the study. However, participants that met the eligibility requirements with BMI> 30 kg/m 2 were included (37 subjects). The final study sample included 1,716 eligible persons. All procedures were approved by the Ethics Committee of Ehime University School of Medicine.
Evaluation of Risk Factors
We measured blood pressure in the right upper arm of participants in a seated position using an automatic oscillometric blood pressure recorder. Cigarette smoking was quantified based on daily consumption and on duration of smoking. Fasting total cholesterol (T-C), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), fasting blood glucose (FBG), creatinine (enzymatic method), and uric acid were measured during fasting. Low-density lipoprotein cholesterol (LDL-C) levels were calculated using the Friedewald formula (10). Participants with TG levels ≥ 400 mg/dL were excluded (24 cases). The presence of diabetes was defined as a history of treatment for diabetes. Estimated GFR was calculated using the following equation (11, 12) : 
Statistical Analysis
Statistical analysis was performed using SPSS 10.0J (Statistical Package for Social Science, Inc., Chicago, USA). All values are expressed as mean±SD, unless otherwise specified. 
Results
Background Factors in Subjects Categorized
According to BMI 2 ) subjects. Systolic blood pressure (SBP), diastolic blood pressure (DBP), T-C, log TG, LDL-C, log FBG, serum creatinine and uric acid were significantly higher in the higher BMI group, but age and HDL-C were significantly lower in that group. There were no inter-group differences in sex or smoking status.
Estimated GFR of Subjects Categorized by BMI
Estimated GFR values decreased progressively with increasing BMI (Table 2) , especially in those with lower normal weight compared with the higher BMI groups. Moreover, the higher weight groups had a higher prevalence of participants with an eGFR of < 90 mL/min/1.73 m 2 . Table 3 shows the relationship between participant characteristics and eGFR. The BMI (r= −0.054), along with age, SBP, DBP, log TG, HDL-C and LDL-C, was significantly correlated with eGFR ( Fig. 1) . Stepwise multiple regression analysis using eGFR as an objective variable, adjusted for risk factors as explanatory variables, showed that BMI (β= −0.075) was significantly and independently associated with eGFR as well as log TG, LDL-C and log FBS. 
Relationship of Risk Factors, Including BMI, and eGFR
Association between BMI Categories and Risk for Mildly or Moderately Reduced eGFR
Discussion
To examine the possible contribution of increased BMI to renal function in the general population, we studied the relationship between risk factors and eGFR. This study showed a Several previous studies have shown that increased BMI is a risk factor for development of CKD. In a community-based cross-sectional study in Japan, Ishizaka et al. found that increased BMI was associated with low eGFR only in men (13) . The OR for developing new-onset kidney disease, defined as a GFR of less than 59.3 mL/min/1.73 m 2 in women and less than 64.3 mL/min/1.73 m 2 in men, was 23% (OR, 1.23; 95% CI, 1.08-1.41) for one SD increase in BMI (14) . Gelber et al. (15) reported that baseline BMI was consistently associated with increased CKD risk in a study of 11,104 initially healthy men who participated in the Physicians' Health Study. After a follow-up that occurred an average of 14 years later, 1,377 participants (12.4%) had a GFR of < 60 mL/min/ 1.73 m 2 . Baseline BMI can also predict future risk for endstage renal disease (ESRD) (16) . Baseline BMI predicted future risk for ESRD in Japanese men (OR, 1.27; 95% CI, 1.12-1.45), but not women (OR, 0.95; 95% CI, 0.83-1.09) (17) , as well as in a Chinese cohort, for which there was a Jshaped association between BMI and all-cause ESRD (18) . Most studies found CKD risks only among persons with a baseline BMI greater than or equal to 25 kg/m 2 , whereas we found that upper normal weight (BMI, 22.0 to 24.9 kg/m 2 ), as well as overweight or obesity (≥ 25 kg/m 2 ), was significantly associated with a risk for mildly and moderately decreased eGFR (< 90 and < 60 mL/min/1.73 m 2 , respectively). The mechanisms that lead to renal dysfunction in overweight and obese individuals are not completely understood. Being overweight markedly increases risk for hypertension and diabetes (19) , which can contribute to CKD (20) (21) (22) . In the current study, BMI remained a risk factor even after adjustment for smoking status, blood pressure, lipids and FBG. However, some participants may have had undiagnosed hypertension and diabetes, and participants with increased BMI are more likely to develop diabetes and hypertension. Moreover, in men, the prevalence of microalbuminuria increased from 9.5% for normal weight individuals (BMI< 25.0 kg/m 2 ) to 18.3% in overweight individuals (BMI, 25.0 to 29.9 kg/m 2 ) and to 29.3% in those with obesity (BMI≥ 30.0 kg/m 2 ). In women, these percentages were 6.6%, 9.2% and 16.0%, respectively. Renal blood flow and glomerular filtration rate increases in obesity, which may be fol- Body mass index was calculated using weight in kg divided by the square of the height in m. Estimated glomerular filtration rate=194 × Cr lowed by microalbuminuria, leading to the development of overt proteinuria and, eventually, progressive CKD (23) . This microalbuminuria phase is followed by a progressive fall in GFR (24) .
Increased BMI and decreased renal function may be associated with other non-traditional risk factors not examined in this study, including low-grade inflammation (i.e., C-reactive protein) (25) , homocysteinemia (26) , oxidative stress (27) , hyperlipidemia (6, 7) , hyperleptinemia (28), increased sympathetic activity (29) , hyperfiltration caused by insulin resistance (30), renin-angiotensin system (31), and elevated cytokines (32) . All these risk factors result in atherosclerosis. CKD may be complicated by both the severity and duration of atherosclerosis, and vice versa.
In our study, 26.3% of men and 22.8% of women were overweight or obese (with a BMI of ≥ 25 kg/m 2 ); in another study of Japanese workers, 31.2% of men and 19.5% of women were reported to be overweight or obese (33) . Moreover, these tendencies are expected to increase in Japan in the future. Excess body weight could therefore contribute to the substantially large burden of CKD in such populations. We have modeled a 5.0 kg/m 2 increase in BMI, which corresponds to weight gains of about 13 kg in men and 11 kg in women who have an average BMI of 23.0 kg/m 2 as in this population. Therefore, excess body weight could become the important life style factor that contributes to CKD occurrence in Japan.
Some limitations of this study must be considered. First, the cross-sectional study design is limited in its ability to eliminate causal relationships between BMI and eGFR. The cumulative effects of excess body weight over several decades, the effect of weight-change periods or past maximum weight in the life-course of individuals, and interactions with other risk factors remain to be explored (34) . Second, estimation of GFR tends to be less accurate in subjects with normal renal function and CKD than estimation of GFR when inulin clearance is used, but is more accurate than serum creatinine or the Cockcroft-Gault equation (35) . Third, our definition of eGFR is based on a single assessment of serum creatinine, which may introduce a misclassification bias. Finally, in this study, we might misclassify CKD with eGFR> 60 mL/min/1.73 m 2 and proteinuria as mildly reduced renal function because we defined reduced renal function as reduced eGFR irrespective of the presence or absence of proteinuria. Therefore the demographics and referral source may limit the generalization of the results.
In conclusion, the present study showed that BMI is strongly associated with decreased eGFR in the general population. The underlying mechanism behind this relationship is unclear, but it seems to be independent from traditional cardiovascular risk factors such as age, hypertension, dyslipidemia, and diabetes. For community-dwelling healthy persons, prospective population-based studies are needed to investigate the mechanisms underlying this association and to determine whether effective interventions that reduce BMI in adult populations will reduce CKD risks.
